BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36231019)

  • 1. Elucidating the Anti-Tumorigenic Efficacy of Oltipraz, a Dithiolethione, in Glioblastoma.
    Kapoor-Narula U; Lenka N
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.
    Bijangi-Vishehsaraei K; Reza Saadatzadeh M; Wang H; Nguyen A; Kamocka MM; Cai W; Cohen-Gadol AA; Halum SL; Sarkaria JN; Pollok KE; Safa AR
    J Neurosurg; 2017 Dec; 127(6):1219-1230. PubMed ID: 28059653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide.
    Su YK; Bamodu OA; Tzeng YM; Hsiao M; Yeh CT; Lin CM
    Phytomedicine; 2019 Aug; 61():152840. PubMed ID: 31035045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
    Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echinacoside (ECH) suppresses proliferation, migration, and invasion of human glioblastoma cells by inhibiting Skp2-triggered epithelial-mesenchymal transition (EMT).
    Shi S; Qin Y; Chen D; Deng Y; Yin J; Liu S; Yu H; Huang H; Chen C; Wu Y; Zou D; Wang Z
    Eur J Pharmacol; 2022 Oct; 932():175176. PubMed ID: 35995211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tumorsphere model of glioblastoma multiforme with intratumoral heterogeneity for quantitative analysis of cellular migration and drug response.
    Gudbergsson JM; Kostrikov S; Johnsen KB; Fliedner FP; Stolberg CB; Humle N; Hansen AE; Kristensen BW; Christiansen G; Kjær A; Andresen TL; Duroux M
    Exp Cell Res; 2019 Jun; 379(1):73-82. PubMed ID: 30922921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.
    Nitta RT; Gholamin S; Feroze AH; Agarwal M; Cheshier SH; Mitra SS; Li G
    Oncogene; 2015 Jul; 34(28):3688-99. PubMed ID: 25241897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction.
    Guo H; Liu C; Yang L; Dong L; Wang L; Wang Q; Li H; Zhang J; Lin P; Wang X
    Mol Carcinog; 2016 Jan; 55(1):77-89. PubMed ID: 25557841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells.
    Tilghman J; Wu H; Sang Y; Shi X; Guerrero-Cazares H; Quinones-Hinojosa A; Eberhart CG; Laterra J; Ying M
    Cancer Res; 2014 Jun; 74(11):3168-79. PubMed ID: 24710409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nestin Is Required for Spindle Assembly and Cell-Cycle Progression in Glioblastoma Cells.
    Wang Q; Wu H; Hu J; Fu H; Qu Y; Yang Y; Cai KQ; Efimov A; Wu M; Yen T; Wang Y; Yang ZJ
    Mol Cancer Res; 2021 Oct; 19(10):1651-1665. PubMed ID: 34158391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cytotoxic effects of new derivatives of pyrazino[1,2-a] benzimidazole on isolated human glioblastoma cells and mitochondria.
    Rahimifard M; Haghi-Aminjan H; Hadjighassem M; Pourahmad Jaktaji R; Bagheri Z; Azami Movahed M; Zarghi A; Pourahmad J
    Life Sci; 2021 Dec; 286():120022. PubMed ID: 34626606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells.
    Seifert C; Balz E; Herzog S; Korolev A; Gaßmann S; Paland H; Fink MA; Grube M; Marx S; Jedlitschky G; Tzvetkov MV; Rauch BH; Schroeder HWS; Bien-Möller S
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
    Shin HJ; Lee S; Jung HJ
    J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells.
    Noh H; Yan J; Hong S; Kong LY; Gabrusiewicz K; Xia X; Heimberger AB; Li S
    Oncotarget; 2016 Nov; 7(44):72021-72032. PubMed ID: 27713131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.